Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Menopause01:28

Menopause

250
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
250
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Aging01:26

Aging

182
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
182
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

508
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
508
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

4.6K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
4.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Vascular risk at menopause: The importance of a cardio-gynecological program.

Maturitas·2026
Same author

Aortic Segments-Depending Hypertensive Remodeling Is Driven by Mitochondrial Fusion Dysfunction.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT).

Maturitas·2026
Same author

Integrin α<sub>v</sub> contributes to the regulation of vascular smooth muscle cell stiffness.

Scientific reports·2026
Same author

Venous Thromboembolism Risk Associated With Relugolix-estradiol-norethisterone Acetate Combination Therapy.

Journal of the Endocrine Society·2026
Same author

Impact of obesity and preconceptional bariatric surgery on feto-placental unit in a rat model: a preliminary study.

Journal of developmental origins of health and disease·2026
Same journal

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026
Same journal

Immunomodulatory endothelial cells contribute to T cell recruitment and activation via antigen presentation on MHC II.

Cardiovascular research·2026
Same journal

Syntabulin promotes heart failure by enhancing SR-mitochondria tethering and impairing mitofission.

Cardiovascular research·2026
Same journal

Restraining fibrosis in cardiac repair.

Cardiovascular research·2026
Same journal

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

Cardiovascular research·2026
Same journal

Urea-cycle control of fibroblast energetics after myocardial infarction.

Cardiovascular research·2026
查看所有相关文章

相关实验视频

Updated: Sep 11, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K

从性激素下降到激素治疗:随着年龄的增长,对心血管风险的影响.

Coralie Fontaine1, Anna Gosset1, Morgane Davezac1

  • 1Institut National de la Santé et de la Recherche Médicale (Inserm) U1297, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), University of Toulouse, Toulouse CHU, 1 avenue Jean Poulhès, 31 400 Toulouse, France.

Cardiovascular research
|August 14, 2025
PubMed
概括
此摘要是机器生成的。

激素治疗是一种激素治疗.

关键词:
年龄化 衰老 衰老雄激素是一种基.心血管疾病是什么心血管疾病雌激素是一种雌激素.更年期 绝经 绝经性激素是一种性激素.

更多相关视频

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

相关实验视频

Last Updated: Sep 11, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

科学领域:

  • 心血管健康的心血管健康
  • 内分泌学 在内分泌学.
  • 老年学是一门学科.

背景情况:

  • 老龄化是主要的心血管风险因素,影响男性和女性.
  • 随着年龄的增长,性激素 (雌激素和) 的下降会对心血管健康产生负面影响.
  • 激素替代疗法对心血管的影响,特别是随着年龄的增长,仍然存在争议.

研究的目的:

  • 分析性激素 (雌激素和) 在心血管健康和衰老中的作用.
  • 审查不同年龄组对激素治疗用于心血管保护的临床研究.
  • 探索性激素作用的机制及其在性别肯定护理中的相关性.

主要方法:

  • 对性激素和心血管疾病的临床研究和实验模型的审查.
  • 激素剂量,度及其生理与药理效应的分析.
  • 检查来自大型试验的数据,如妇女健康倡议.

主要成果:

  • 雌激素治疗显示了年龄相关的效果,在年轻女性中具有保护作用,但在老年女性中与某些孕激素结合时会增加风险.
  • 孕激素的类型和患者年龄是激素治疗心血管结果的关键因素.
  • 在男性中,丸激素治疗对心血管的影响需要进一步澄清.

结论:

  • 激素治疗对心血管的影响是复杂的,受激素类型,剂量,年龄和配方的影响.
  • 了解性激素的作用对于管理与年龄有关的心血管风险和性别肯定激素治疗至关重要.
  • 需要进一步的研究来澄清丸激素在男性心血管健康中的作用.